Animation - Understanding Clinical Trials in Lung Cancer

Slide Show - Understanding Clinical Trials in Lung Cancer

Infographic - Understanding Clinical Trials in Lung Cancer

Expert Videos

1. What is a clinical trial for lung cancer?

2. Why are clinical trials needed for lung cancer?

3. What are the different types and phases of lung cancer clinical trials?

4. What is a clinical trial drug treatment protocol?

5. Who can participate in a lung cancer clinical trial?

6. How long will a lung cancer clinical trial typically last?

7. How are lung cancer treatments approved, based on clinical trial outcomes?

8. How do lung cancer patients find a clinical trial that is a good fit for them?

9. Will I be randomized to receive one treatment versus another in a clinical trial?

10. Why is it important to have diversity in lung cancer clinical trials?

Patient Videos

11. Why did you decide to join a lung cancer clinical trial?

12. What was the clinical trial enrollment process like for you?

13. What was your overall experience in the lung cancer clinical trial?

14. What advice do you have for other people about participating in clinical trials for lung cancer?

15. How did you use ClinicalTrials.gov to find a lung cancer clinical trial?

Download Infographic

Infographic - Understanding Clinical Trials in Lung Cancer

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

NGS and CGP for Lung Cancer

Treatment and Management of Lung Cancer

Immunotherapy for Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Section: Clinical Trials in Lung Cancer

Animation - Understanding Clinical Trials in Lung Cancer

Slide Show - Understanding Clinical Trials in Lung Cancer

Infographic - Understanding Clinical Trials in Lung Cancer

Expert Videos

1. What is a clinical trial for lung cancer?

2. Why are clinical trials needed for lung cancer?

3. What are the different types and phases of lung cancer clinical trials?

4. What is a clinical trial drug treatment protocol?

5. Who can participate in a lung cancer clinical trial?

6. How long will a lung cancer clinical trial typically last?

7. How are lung cancer treatments approved, based on clinical trial outcomes?

8. How do lung cancer patients find a clinical trial that is a good fit for them?

9. Will I be randomized to receive one treatment versus another in a clinical trial?

10. Why is it important to have diversity in lung cancer clinical trials?

Patient Videos

11. Why did you decide to join a lung cancer clinical trial?

12. What was the clinical trial enrollment process like for you?

13. What was your overall experience in the lung cancer clinical trial?

14. What advice do you have for other people about participating in clinical trials for lung cancer?

15. How did you use ClinicalTrials.gov to find a lung cancer clinical trial?

Patient Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.